Mutant IDH1-IN-3
Product Specifications
CAS Number
1648909-73-2
Target
Isocitrate Dehydrogenase (IDH)
Related Pathways
Metabolism
Bioactivity
Mutant IDH1-IN-3 (Compound 1) is a selective allosteric inhibitor targeting the mutant isocitrate dehydrogenase 1 (IDH1), with an IC50 of 13 nM for R132HIDH1. It effectively suppresses the production of D-2-hydroxyglutarate (2HG) in cells and is applicable for research in oncology.
Smiles
OC=1C(=CC(=CC1CN2C=NC=C2)C(C)(C)CC(C)(C)C)CN3C=NC=C3
Molecular Formula
C22H30N4O
Molecular Weight
366.5
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Spiro[11H-dibenz[b,e]azepine-11,2'-[1,3]dioxolan]-6(5H)-one](https://cdn.genprice.uk/products/572/3665293370449/imageurl/trc-s679260-50mg.webp)
TRC-S679260-50MG 50 mg
Spiro[11H-dibenz[b,e]azepine-11,2'-[1,3]dioxolan]-6(5H)-one
Sign In for Pricing
View Details 
BNC942743-500 1x 500 µL
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details